We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Risperdal Gynecomastia Defense Verdict Reversed On Appeal For ‘Expert’ Testimony

(November 14, 2017, 12:25 PM EST) -- PHILADELPHIA — A Pennsylvania state appeals court panel on Nov. 13 reversed a Risperdal gynecomastia defense verdict, finding that the trial court erred in not treating physician assistant’s testimony as that of a causation expert (W.C. v. Janssen Pharmaceuticals, Inc., et al., No. 2451 EDA 2015, Pa. Super., 2017 Pa. Super. LEXIS 909).

(Opinion available.  Document #28-171116-010Z.)

A plaintiff identified only as W.C., was 6 when he was prescribed the atypical antipsychotic drug Risperdal in 2001 to treat attention deficit/hyperactivity disorder and oppositional defiant disorder.  Risperdal...
To view the full article, register now.